In the group of cancer patients, we found a significantly higher portion of women (4.5%, 10/222) with more than two copies of E2F1, compared with controls where none of subjects harboured E2F1 CNVs > 2 (0%, 0/200; p = 0.002). The gene discussed is E2F1; the disease is cancer.